We also found that RhoG is activated by cMet and EGFR, two receptors that are deregulated in glioblastoma tumors[31,32,34], further underlining the relevance of RhoG-mediated signaling in the context of glioblastoma. The gene discussed is MET; the disease is glioblastoma.